Every 8-K that Dolby Laboratories, Inc. (DLB) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow DLB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DLB filings page.
Dolby Laboratories, Inc. (DLB) announced a CEO leadership transition, appointing Marc Whitten as President, Chief Executive Officer and director effective August 27, 2026, following the retirement of long-time CEO Kevin Yeaman, who will remain as a paid advisor through 2027 under a consulting agreement.
Whitten’s employment agreement provides a $1,000,000 annual salary, a target annual bonus equal to 100% of salary beginning in fiscal 2027 (with fiscal 2027 paid at target), a $2,100,000 sign-on bonus subject to repayment conditions, and up to $200,000 in relocation reimbursement, plus significant equity awards under a new inducement plan and participation in the 2027 equity cycle. He is entitled to enhanced cash severance, COBRA reimbursements and equity vesting upon qualifying terminations, with higher benefits in connection with a Change in Control.
Yeaman’s transition package includes $40,000 per month for six months of consulting, continued equity vesting during the consulting period, a 2026 bonus based on actual performance, COBRA reimbursement through December 31, 2027, up to $200,000 in coaching and $15,000 for legal fees. The Board also adopted a 2026 Inducement Stock Plan reserving 2,500,000 Class A shares, and approved one-time $3,000,000 retention RSU awards for two senior executives, vesting after two years.
Dolby Laboratories, Inc. reported financial results for the third quarter of fiscal 2026, with total revenue of 304,995 (in thousands) versus 315,546 (in thousands) a year earlier. Net income attributable to Dolby was 28,602 (in thousands), or diluted earnings per share of $0.30, compared with $0.48 in the prior-year quarter. Non-GAAP net income was 65,149 (in thousands), or non-GAAP diluted earnings per share of $0.69.
For the fiscal year-to-date, revenue was 1,047,331 (in thousands) and net income attributable to Dolby was 176,844 (in thousands). The board declared a cash dividend of $0.36 per share on Class A and Class B common stock and increased the stock repurchase program by $350 million, bringing remaining authorization to approximately $427 million. Dolby also provided fourth-quarter and full-year fiscal 2026 guidance, including GAAP diluted earnings per share of $0.78–$0.93 for Q4 and $2.62–$2.77 for the full year, and corresponding non-GAAP diluted earnings per share of $1.13–$1.28 and $4.25–$4.40.
Dolby Laboratories reported modestly higher results for its second quarter of fiscal 2026 and maintained its dividend. Total revenue was $395.6 million, up from $369.6 million a year earlier, driven mainly by licensing revenue of $372.2 million. GAAP net income attributable to Dolby was $94.9 million, compared with $91.8 million, and GAAP diluted EPS was $0.99. Non-GAAP net income reached $131.3 million with non-GAAP diluted EPS of $1.37. Year-to-date operating cash flow was $147.3 million. The company declared a quarterly cash dividend of $0.36 per share on Class A and B stock, payable on May 20, 2026 to stockholders of record on May 12, 2026. For fiscal 2026, Dolby targets a GAAP gross margin of 88%, non-GAAP gross margin of 90%, GAAP operating margin around 21% and non-GAAP operating margin around 34%, with GAAP diluted EPS guidance of $2.66–$2.81 and non-GAAP diluted EPS of $4.30–$4.45.
Dolby Laboratories, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on February 3, 2026 via live webcast. Holders of Class A and Class B common stock, which carry one vote and ten votes per share respectively, voted together as a single class on all items.
All eight director nominees, including Kevin Yeaman, David Dolby, and others, were elected, each receiving over 384 million votes for, with broker non-votes of 3,884,937 on each director proposal. Stockholders also approved, on an advisory basis, the compensation of the named executive officers, with 396,794,929 votes for and 2,216,964 against.
In addition, stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 25, 2026, with 400,209,219 votes for and 2,718,973 against. Overall, the meeting confirmed the existing board slate, executive pay program, and external auditor.
Dolby Laboratories, Inc. reported that it has released its financial results for the fiscal quarter ended December 26, 2025 through a press release furnished as an exhibit. The filing itself does not detail the numbers but points readers to the accompanying press release for full results.
The company also declared a cash dividend of $0.36 per share on its Class A and Class B common stock, payable on February 18, 2026 to stockholders of record as of the close of business on February 10, 2026. Dolby reiterates that it shares important information through its websites, SEC filings, press releases, and public calls.
Dolby Laboratories, Inc. reported that it has released its financial results for the fiscal quarter and fiscal year ended September 26, 2025, via a press release that is incorporated by reference as Exhibit 99.1. The company also declared a cash dividend of $0.36 per share on its Class A and Class B common stock, payable on December 10, 2025, to stockholders of record as of the close of business on December 2, 2025. Dolby noted that it regularly shares information with the public through its main website, investor relations site, SEC filings, press releases, conference calls, and webcasts.
Dolby Laboratories approved its 2026 Dolby Executive Bonus Plan for selected officers. The plan sets a target bonus of 100% of base salary for CEO Kevin Yeaman and 65% of base salary for each other named executive officer. Eligibility is limited to executives chosen by the Compensation Committee.
Actual payouts will be determined by target amounts adjusted for performance against non-GAAP operating income, revenue and/or other metrics, as assessed by the Committee. The Committee retains discretion to adjust awards, and the CEO may recommend increases or decreases of up to 25% for other executives. Plan funding is capped at 150% of target, and no payment may exceed the limitations in the company’s 2020 Stock Plan.